Zota Health Care last traded at ₹1,286.50 (2026-10-13). Over the past month the stock moved +17.0%, three months the stock moved +9.8%, year the stock moved -11.0%. Its closing range over 52 weeks is ₹1,028.10 – ₹1,685.10, with the latest close 23.7% below the high.
Closing prices up to 2026-10-13.
Zota Health Care Limited is a renowned pharmaceutical company that manufactures, markets, and exports pharmaceutical, ayurvedic, nutraceutical, and over-the-counter (OTC) products across boundaries into the semi-regulated and regulated markets of Asian Countries markets of African Countries, Russian Countries & Latin America.[1]
Business segments & Revenue 9MFY26[1][2] A. Domestic sales (13%):[3] The company’s domestic marketing business(oldest vertical) is supported by a distribution network of 1,050+ distributors and a portfolio of 4,000+ products across multiple therapeutic segments. It sources formulations from domestic manufacturers, including those recognised by global health agencies, and distributes them across the country.
In the latest quarter (Jun 2026), Zota Health Care reported sales of ₹174.00 crore (+67.3%) and net profit of ₹-44.00 crore, compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 174.00 | -12.00 | -7.00 | -44.00 | -12.58 |
| Mar 2026 | 163.00 | 9.00 | 5.00 | -14.00 | -4.09 |
| Dec 2025 | 143.00 | 0.00 | -0.30 | -30.00 | -8.73 |
| Sep 2025 | 129.00 | 6.00 | 4.90 | -16.00 | -5.20 |
| Jun 2025 | 104.00 | 4.00 | 3.80 | -14.00 | -4.81 |
| Mar 2025 | 97.00 | 2.00 | 2.50 | -13.00 | -4.50 |
| Dec 2024 | 72.00 | -6.00 | -8.00 | -19.00 | -6.78 |
| Sep 2024 | 67.00 | -1.00 | -1.30 | -12.00 | -4.41 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +48.9% | +53.2% | +94.0% | +85.7% | +92.5% | +98.6% | +68.0% | +67.3% |
| Operating profit growth | -125.0% | -300.0% | – | – | – | – | +350.0% | -400.0% |
| Net profit growth | – | – | – | – | – | – | – | – |
| EPS growth | – | – | – | – | – | – | – | – |
| OPM % | -1.3% | -8.0% | 2.5% | 3.8% | 4.9% | -0.3% | 5.0% | -7.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Zota Health Care reported sales of ₹539.00 crore (+84.0%) and net profit of ₹-74.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 539.00 | 19.00 | 3.00 | -74.00 | -21.35 |
| Mar 2025 | 293.00 | -6.00 | -2.00 | -57.00 | -19.70 |
| Mar 2024 | 180.00 | 8.00 | 4.00 | -14.00 | -5.55 |
| Mar 2023 | 139.00 | 7.00 | 5.00 | -6.00 | -2.29 |
| Mar 2022 | 131.00 | 15.00 | 11.00 | 9.00 | 3.54 |
| Mar 2021 | 106.00 | 1.00 | 1.00 | 0.00 | -0.09 |
| Mar 2020 | 95.00 | 5.00 | 5.00 | 3.00 | 1.12 |
| Mar 2019 | 85.00 | 8.00 | 9.00 | 6.00 | 2.26 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +51.8% | +11.8% | +11.6% | +23.6% | +6.1% | +29.5% | +62.8% | +84.0% |
| Operating profit growth | +0.0% | -37.5% | -80.0% | +1400.0% | -53.3% | +14.3% | -175.0% | – |
| Net profit growth | +50.0% | -50.0% | -100.0% | – | -166.7% | – | – | – |
| EPS growth | +6.6% | -50.4% | -108.0% | – | -164.7% | – | – | – |
| OPM % | 9.0% | 5.0% | 1.0% | 11.0% | 5.0% | 4.0% | -2.0% | 3.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Zota Health Care.
Get Free AI Stock Analysis FREE →Zota Healthcare: Brokerage Eyes Growth as Store Efficiency Rises - Whalesbook
Zota Health Care shares were last quoted at ₹1,286.50 (-2.8% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Zota Health Care has a price-to-earnings (P/E) ratio of 193.71 and a price-to-book (P/B) ratio of 7.13. The industry P/E is 53.33.
The 52-week high of Zota Health Care is ₹1,740.00 and the 52-week low is ₹1,022.00.
The market capitalisation of Zota Health Care is about ₹4,628.99 crore.
In the latest quarter (Jun 2026), Zota Health Care reported sales of ₹174.00 crore (+67.3%) and net profit of ₹-44.00 crore, compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Zota Health Care has a 3-year ROE of -20.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 62.02% of Zota Health Care.
Zota Health Care belongs to the Pharmaceuticals & Drugs sector.